Skip to main content
Erschienen in: Heart and Vessels 9/2016

19.09.2015 | Original Article

Risk factors and serological markers of liver cirrhosis after Fontan procedure

verfasst von: Mikiko Shimizu, Kenji Miyamoto, Yunosuke Nishihara, Gaku Izumi, Shuji Sakai, Kei Inai, Toshio Nishikawa, Toshio Nakanishi

Erschienen in: Heart and Vessels | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Liver cirrhosis (LC), which may result in hepatic failure or cancer, has been reported in patients after Fontan procedure. The purpose of this study was to clarify the frequency and histological characteristics of LC, and to evaluate the risk factors and serological markers of LC with Fontan circulation. Retrospective review of contrast-enhanced CT scans (CT) of the liver was carried out in 57 patients after Fontan procedure. Patients were divided into two groups: LC group (n = 31) and no LC group (n = 26). Age at Fontan procedure, duration after Fontan procedure, catheterization data, and history of failing Fontan circulation were compared between groups. Serological data including γ-GTP and hyaluronic acid were compared. Histology of autopsy specimens was assessed when available. Duration after Fontan procedure was significantly longer in LC group than no LC group. History of failing Fontan circulation was more frequent in LC group than in no LC group. There was no correlation between type of procedure (APC/Bjork/lateral tunnel/TCPC) and LC in this series. Serum hyaluronic acid, γ-GTP, and Forns index were significantly higher in LC group. Significant risk factors for LC were duration after Fontan procedure (>20 years). In autopsy specimens, histopathological changes of LC were observed predominantly in the central venous area. LC diagnosed with CT is frequent in patients long after Fontan procedure, especially after 20 years. Hyaluronic acid and γ-GTP could be useful markers to monitor the progression of liver fibrosis in Fontan patients.
Literatur
2.
Zurück zum Zitat Motoki N, Ohuchi H, Miyazaki A, Yamada O (2009) Clinical Profiles of Adult patient with single ventricle physiology. Circ J 73(9):1711–1716CrossRefPubMed Motoki N, Ohuchi H, Miyazaki A, Yamada O (2009) Clinical Profiles of Adult patient with single ventricle physiology. Circ J 73(9):1711–1716CrossRefPubMed
3.
Zurück zum Zitat Sarkola T, Jaeggi E, Slorach C, Hui W, Bradley T, Redington AN (2013) Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up. Heart Vessels 28(1):66–75CrossRefPubMed Sarkola T, Jaeggi E, Slorach C, Hui W, Bradley T, Redington AN (2013) Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up. Heart Vessels 28(1):66–75CrossRefPubMed
4.
Zurück zum Zitat Olivier M, O’Leary PW, Pankratz VS, Lohse CM, Walsh BE, Tajik AJ, Seward JB (2003) Serial Doppler assessment of diastolic function before and after the Fontan operation. J Am Soc Echocardiogr 16:1136–1143CrossRefPubMed Olivier M, O’Leary PW, Pankratz VS, Lohse CM, Walsh BE, Tajik AJ, Seward JB (2003) Serial Doppler assessment of diastolic function before and after the Fontan operation. J Am Soc Echocardiogr 16:1136–1143CrossRefPubMed
5.
Zurück zum Zitat Shachar GB, Fuhrman BP, Wang Y, Lucas RV Jr, Lock JE (1982) Rest and exercise hemodynamics after the Fontan procedure. Circulation 65:1043–1048CrossRefPubMed Shachar GB, Fuhrman BP, Wang Y, Lucas RV Jr, Lock JE (1982) Rest and exercise hemodynamics after the Fontan procedure. Circulation 65:1043–1048CrossRefPubMed
6.
Zurück zum Zitat Nieuwenhuizen RC, Peter M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82(1):40–46CrossRefPubMedPubMedCentral Nieuwenhuizen RC, Peter M, Lubbers LJ, Trip MD, Tijssen JG, Mulder BJ (1999) Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82(1):40–46CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Tomita H, Yamada O, Ohuchi Ono Y, Arakaki Y, Yagihara T, Echigo S (2001) Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 11(1):62–66CrossRefPubMed Tomita H, Yamada O, Ohuchi Ono Y, Arakaki Y, Yagihara T, Echigo S (2001) Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 11(1):62–66CrossRefPubMed
8.
Zurück zum Zitat Cheung EW, Chay GW, Ma ES, Systemic Cheung YF (2005) Oxygen saturations and coagulation factor abnormalities before and after the Fontan procedure. Am J Cardiol 96(11):1571–1575CrossRefPubMed Cheung EW, Chay GW, Ma ES, Systemic Cheung YF (2005) Oxygen saturations and coagulation factor abnormalities before and after the Fontan procedure. Am J Cardiol 96(11):1571–1575CrossRefPubMed
9.
Zurück zum Zitat Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kuromann O, Pedersen J, Sorensen KE (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1):61–65CrossRefPubMedCentral Ravn HB, Hjortdal VE, Stenbog EV, Emmertsen K, Kuromann O, Pedersen J, Sorensen KE (2001) Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 85(1):61–65CrossRefPubMedCentral
10.
Zurück zum Zitat Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP (2008) Hepatic fibrosis and cirrhosis in Fontan circulation: a detailed morphological study. J Clin Pathol 61(4):504–508CrossRefPubMed Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP (2008) Hepatic fibrosis and cirrhosis in Fontan circulation: a detailed morphological study. J Clin Pathol 61(4):504–508CrossRefPubMed
11.
Zurück zum Zitat Kieswetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR (2007) Hepatic changes in failing Fontan circulation. Heart 93(5):579–584CrossRef Kieswetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, Haw M, Cope R, Salmon AP, Sivaprakasam MC, Kendall T, Keeton BR, Iredale JP, Veldtman GR (2007) Hepatic changes in failing Fontan circulation. Heart 93(5):579–584CrossRef
12.
Zurück zum Zitat Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRefPubMed Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRefPubMed
13.
Zurück zum Zitat Friedrich-Rust M, Koch C, Rentzsch A, Sarrazim C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cariovasc Surg 135:560–567CrossRef Friedrich-Rust M, Koch C, Rentzsch A, Sarrazim C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schäfers HJ, Zeuzem S, Abdul-Khaliq H (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cariovasc Surg 135:560–567CrossRef
14.
Zurück zum Zitat Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: concise review. Am J Gastroenterol 99(6):1160–1174CrossRefPubMed Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: concise review. Am J Gastroenterol 99(6):1160–1174CrossRefPubMed
15.
Zurück zum Zitat Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 51(suppl 1):17–26CrossRefPubMed Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 51(suppl 1):17–26CrossRefPubMed
16.
Zurück zum Zitat Ginde S, Hohenwalter D, Foley D, Sowinski J, Bartz J, Venkatapuram S, Weinberg C, Tweddell S, Earing G (2012) Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis 7:235–242CrossRefPubMed Ginde S, Hohenwalter D, Foley D, Sowinski J, Bartz J, Venkatapuram S, Weinberg C, Tweddell S, Earing G (2012) Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis 7:235–242CrossRefPubMed
17.
Zurück zum Zitat Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, Spengler U (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145CrossRefPubMed Terjung B, Lemnitzer I, Dumoulin FL, Effenberger W, Brackmann HH, Sauerbruch T, Spengler U (2003) Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67:138–145CrossRefPubMed
18.
Zurück zum Zitat Baek S, Bae J, Ho S, Kim B, Lee Y, Noh L, Park A, Lee W (2010) Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 96:1750–1755CrossRefPubMed Baek S, Bae J, Ho S, Kim B, Lee Y, Noh L, Park A, Lee W (2010) Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart 96:1750–1755CrossRefPubMed
19.
Zurück zum Zitat Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by simple predictive model. Hepatology 36:986–992CrossRefPubMed Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by simple predictive model. Hepatology 36:986–992CrossRefPubMed
20.
Zurück zum Zitat Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pudifin DJ (1986) Sampling variability and its influence on the liver. Lancet 1:523–525CrossRefPubMed Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pudifin DJ (1986) Sampling variability and its influence on the liver. Lancet 1:523–525CrossRefPubMed
21.
Zurück zum Zitat Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Gardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M (1995) Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 89:757–761CrossRefPubMed Angelucci E, Baronciani D, Lucarelli G, Baldassarri M, Galimberti M, Gardini C, Martinelli F, Polchi P, Polizzi V, Ripalti M (1995) Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 89:757–761CrossRefPubMed
22.
Zurück zum Zitat Bedossa P, Dargere D, Paradise V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457CrossRefPubMed Bedossa P, Dargere D, Paradise V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457CrossRefPubMed
23.
Zurück zum Zitat Hayashi T, Inuzuka R, Shindo T, Hirata Y, Shimizu N, Oka A (2014) Serum Hyaluronic acid concentration in Fontan circulation: Correlation with hepatic function and portal vein hemodynamics. Pediatr Cardiolo 35:608–615CrossRef Hayashi T, Inuzuka R, Shindo T, Hirata Y, Shimizu N, Oka A (2014) Serum Hyaluronic acid concentration in Fontan circulation: Correlation with hepatic function and portal vein hemodynamics. Pediatr Cardiolo 35:608–615CrossRef
Metadaten
Titel
Risk factors and serological markers of liver cirrhosis after Fontan procedure
verfasst von
Mikiko Shimizu
Kenji Miyamoto
Yunosuke Nishihara
Gaku Izumi
Shuji Sakai
Kei Inai
Toshio Nishikawa
Toshio Nakanishi
Publikationsdatum
19.09.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 9/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0743-4

Weitere Artikel der Ausgabe 9/2016

Heart and Vessels 9/2016 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.